Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | GSK3B | P49841 | 2/20 | 0.42 |
| ▸ | GPR139 | Q6DWJ6 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5455373 | 0.82 | KMT2A (0.46) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL8466797 | 0.81 | KMT2A (0.49) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL11371068 | 0.80 | KMT2A (0.45) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL16047247 | 0.76 | KMT2A (0.52) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL31315054 | 0.74 | KMT2A (0.50) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL4201591 | 0.72 | KMT2A (0.49) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL11421328 | 0.72 | ALDH1A1 (0.52) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL7909243 | 0.72 | KMT2A (0.49) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL1641518 | 0.72 | HDAC3 (0.55) | KMT2APTPN1GSK3BGPR139CES1 | |
| SCHEMBL1520392 | 0.72 | KMT2A (0.58) | KMT2APTPN1GSK3BGPR139CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190317040-A1 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-10-17 | — | — | US | disclosed |
| US-10442771-B2 | Trans-base tunnel reader for sequencing | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2019-10-15 | — | — | US | disclosed |
| US-20170204066-A1 | NANOPORE BASED SEQUENCER | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2017-07-20 | — | — | US | disclosed |
| US-9593372-B2 | Nanopore based sequencer | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2017-03-14 | — | — | US | disclosed |
| US-9395352-B2 | Devices and methods for target molecule characterization | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2016-07-19 | — | — | US | disclosed |
| US-20150211059-A1 | TRANS-BASE TUNNEL READER FOR SEQUENCING | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2015-07-30 | — | — | US | disclosed |
| US-8968540-B2 | Trans-base tunnel reader for sequencing | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2015-03-03 | — | — | US | disclosed |
| US-8961757-B2 | Nanopore and carbon nanotube based DNA sequencer | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2015-02-24 | — | — | US | disclosed |
| WO-2014078652-A1 | HEAVY ATOM LABELED NUCLEOSIDES, NUCLEOTIDES, AND NUCLEIC ACID POLYMERS, AND USES THEREOF | ZS GENETICS, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| US-20130186757-A1 | Nanopore and Carbon Nanotube Based Dna Sequencer and A Serial Recognition Elements | ARIZONA BOARD OF REGENTS (US) | 2013-07-25 | — | — | US | disclosed |
| US-20110168562-A1 | Nanopore and Carbon Nanotube Based DNA Sequencer | ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY | 2011-07-14 | — | — | US | disclosed |
| US-20110120868-A1 | Nanopore and Carbon Nanotube Based DNA Sequencer and a Serial Recognition Sequencer | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2011-05-26 | — | — | US | disclosed |
| WO-2010042514-A1 | NANOPORE AND CARBON NANOTUBE BASED DNA SEQUENCER AND A SERIAL RECOGNITION ELEMENTS | ARIZONA BOARD OF REGENTS (US) | 2010-04-15 | — | — | WO | disclosed |
| US-20100084276-A1 | Devices and Methods for Target Molecule Characterization | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-04-08 | — | — | US | disclosed |
| WO-2009117522-A2 | NANOPORE AND CARBON NANOTUBE BASED DNA SEQUENCER AND A SERIAL RECOGNITION SEQUENCER | REINHART, KEVIN (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009117517-A2 | NANOPORE AND CARBON NANOTUBE BASED DNA SEQUENCER | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2008124706-A9 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | UNIV ARIZONA STATE (US) | 2009-05-28 | — | — | WO | disclosed |
| WO-2008124706-A2 | DEVICES AND METHODS FOR TARGET MOLECULE CHARACTERIZATION | ARIZONA BOARD OF REGENTS ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204066-A1 | NANOPORE BASED SEQUENCER | DNMT3A, DNTT, TELO2 | KMT2A 2083/4885PTPN1 1387/4885GSK3B 4686/4885 |
| US-10442771-B2 | Trans-base tunnel reader for sequencing | DNTT, TRDMT1, TELO2 | KMT2A 2184/4885PTPN1 3475/4885GSK3B 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.